Home › Markets › Health Care › PPBT

Purple Biotech Ltd. (PPBT)

PPBT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$1.36
-1.45% on the day
Market cap
$2.2M
Nano cap
Revenue
No annual revenue filed since the period ending 2020-12-31
Net income
No annual revenue filed since the period ending 2020-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerPPBT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryIsrael
IPO year2015
SEC CIK0001614744
SEC industry codePharmaceutical Preparations
Incorporated inL3

Financials

No annual revenue filed since the period ending 2020-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
F-32026-05-20
Latest annual report
ANNUAL REPORT
20-F2026-03-19
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-10-05

Source: SEC EDGAR submissions feed, 576 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SILOSilo Pharma Inc.$1.22-18.12%$2.1M
SPRCSciSparc Ltd.$3.94-3.43%$2.3M
GNPXGenprex Inc.$2.51-6.69%$2.1M
ELABPMGC Holdings Inc.$2.96-2.95%$2.4M
OGENOragenics Inc.$0.4469-0.16%$2.0M
MTNBMatinas Biopharma Holdings Inc.$2.50-8.76%$2.4M
GOVXGeoVax Labs Inc.$0.2656-5.92%$2.7M
KAPAKairos Pharma Ltd.$0.8287-0.40%$2.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier